Buerger's disease, or thromboangiitis obliterans (TAO), is a rare inflammatory vascular disease affecting the small-and mediumsized arteries and superficial veins of the extremities. It typically occurs in young male smokers with an age of onset before 40-45 years. TAO is characterized by chronic and acute phases, the latter often being associated with the occurrence of ischemic ulcerations of the toes and severe pain requiring hospitalization [1]. Amputation of finger or toes occurs in 46% of the cases after 15 years of evolution. Various investigations have been carried out with the aim of identifying an autoimmune mechanism responsible for TAO. Hypersensitivity to types I and III collagen associated with the presence of anti-collagen or anti-elastin antibodies has been shown
. Influence of chronic antiplatelet therapy on PMP levels is unknown [15] , except for cilostazol that decreases PMP levels [16] . Apart 
